Mountain Crest Acquisition

YTD

ALL

Why Robinhood?

You can watch MCAD and buy or sell other stocks, ETFs, and their options commission-free!

About MCAD

Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions.

CEO

Craig R. Jalbert

CEOCraig R. Jalbert

Employees

—

Employees—

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2015

Founded2015

Employees

—

Employees—

MCAD Key Statistics

Market cap

5.40K

Market cap5.40K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

2.36K

Average volume2.36K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.001

52 Week high$0.001

52 Week low

—

52 Week low—

Stock Snapshot

Mountain Crest Acquisition(MCAD) stock is priced at $10.43, giving the company a market capitalization of 5.4K.

Mountain Crest Acquisition(MCAD) stock opened on 2026-04-16 at —. The price climbed to — and dipped to —.

The Mountain Crest Acquisition(MCAD)'s current trading volume is 0, compared to an average daily volume of 2.36K.

People also own

Based on the portfolios of people who own MCAD. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.